San Francisco, CA
Summary
This business focuses on developing nucleic acid medicines, including gene therapies and vaccines, by innovating how cells respond to DNA and mRNA. Their platform aims to enhance therapeutic outcomes by dampening undesirable cellular pathways, addressing both preventative and therapeutic vaccines, rare diseases, and gene therapy. The team is composed of visionary scientists dedicated to improving human health through foundational biological research.
We offer API access to our data.
8 of 8 checks passed
Label
Value
Active Dates
6.4 years — Since Aug 2018
Web Hosting
Platform
E-Mail Provider
Google GSuite
NAICS Code
541714
SIC 4 Digit Code
2836
SIC 2 Digit Code
28
Industry
1. Biotechnology and Pharmaceuticals
2. Research and Development in Biotechnology (except Nanobiotechnology)
No vendors identified.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2018 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2019 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2020 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2021 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2022 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2023 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2024 |
|
|
|
|
|
|
|
|
|
|
|
|